Blood biomarker mix could foresee Alzheimer's risk years before symptoms
A University of Miami study of 1,170 older adults found that blood biomarkers, notably p-tau181 and GFAP, correlate with future cognitive decline years after initial testing, suggesting a combined blood test could flag people at higher risk of cognitive problems before memory loss appears—though it would not predict dementia on its own.